Lol. Excellent. Tomorrow is 10 days since data lock. Time flys. Anticipation and flippers may start to pounce on this .60 share price. A powered phase 2b trial that is an apple to apple comparison to a Goliath like Otezla who by the way is on par to hit 2 billion dollars. Oral psoriasis drugs are king. I hope we crush Otezla!!!!!